Zhenggang Xu

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Jiangsu Province Hospital, Nanjing Medical University · ORCID：0000-0002-9210-2885

发表论文 20 篇 · 总被引 181 次 · h-index 8

代表论文

• Development and validation of a gradient boosting machine to predict prognosis after liver resection for intrahepatic cholangiocarcinoma (2022 · BMC Cancer · 被引 47)
• ESRP1-mediated biogenesis of circPTPN12 inhibits hepatocellular carcinoma progression by PDLIM2/ NF-κB pathway (2024 · Molecular Cancer · 被引 29)
• O-GlcNAcylation of YBX1 drives a glycolysis-histone lactylation feedback loop in hepatocellular carcinoma (2025 · Cancer Letters · 被引 21)
• EIF4A3‐Mediated Biogenesis of CircFADS1 Promotes the Progression of Hepatocellular Carcinoma via Wnt/β‐Catenin Pathway (2025 · Advanced Science · 被引 15)
• Analysis of the efficacy and prognostic factors of PD-1 inhibitors in advanced gallbladder cancer (2021 · Annals of Translational Medicine · 被引 12)
• Identification and validation of a six immune-related gene signature for prediction of biochemical recurrence in localized prostate cancer following radical prostatectomy (2021 · Translational Andrology and Urology · 被引 11)